Preterm labor and delivery are among the most significant causes of neonatal morbidity and mortality. Early identification of women at risk for preterm birth allows for timely intervention, which can include administration of corticosteroids to accelerate fetal lung maturity, tocolytics to delay labor, and the transfer of the mother to a facility equipped to handle preterm infants. The fetal fibronectin test is a valuable tool in this early identification process.
